Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Recently we showed that delta radiomics features (DRF) from daily CT-guided chemoradiation therapy (CRT) is associated with early prediction of treatment response for pancreatic cancer. CA19-9 is a widely used clinical biomarker for pancreatic cancer. The purpose of this work is to investigate if th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasief, Haidy, Hall, William, Zheng, Cheng, Tsai, Susan, Wang, Liang, Erickson, Beth, Li, X. Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960122/
https://www.ncbi.nlm.nih.gov/pubmed/31970088
http://dx.doi.org/10.3389/fonc.2019.01464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960122/
https://www.ncbi.nlm.nih.gov/pubmed/31970088
http://dx.doi.org/10.3389/fonc.2019.01464

Ejemplares similares